Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV
NCT: NCT02560805 · RECRUITING
Brief Summary
The purpose of this study is to find out why patients with post-traumatic stress disorder (PTSD) have an increased risk for heart disease and high blood pressure later in life. A second purpose is to find out what causes PTSD patients to have high adrenaline levels during stress. This study will also test if a medicine called losartan improves high adrenaline levels in patients with PTSD and if a certain gene that has to do with high blood pressure might be associated with high adrenaline levels.
Frequently Asked Questions
What is Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV?
Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV is a clinical trial registered under NCT02560805. Current status: RECRUITING.
What is the status of NCT02560805?
The current status of NCT02560805 (Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV) is: RECRUITING.
When did Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV start?
Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV started on 2015-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.